As of February 10, 2023, the average one-year price target for Vivos Therapeutics is $2.30. The forecasts range from a low of $2.02 to a high of $2.62. The average price target represents an increase ...

Vivo, the Chinese smartphone manufacturer, has officially released its self-developed operating system called BlueOS. The company announced the new OS at its 2023 Vivo Developer Conference. Vivo says ...

HIGHLANDS RANCH, Colo., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing ...

DENVER--(BUSINESS WIRE)--VSB, LLC today announced the opening of its Vivos Breathing Wellness Center in Colorado Springs at 1750 Telstar Drive, Suite 200. As announced earlier in 2018, VSB, an ...

What truly sets BlueOS apart from the competition is its pioneering use of the Rust programming language. This marks a remarkable global first in the creation of an OS framework. The Rust language ...

The vivo V70 is now officially available in the Philippines, bringing its advanced imaging system and AI-powered features to Filipino consumers starting at Php 31,999. Beginning March 14, the ...